Wednesday, April 15, 2020

Biocon Biologics receives EIR from USFDA for 2 manufacturing facilities

Biocon Biologics receives EIR from USFDA for 2 manufacturing facilities The inspection was conducted between September 10 and September 19, 2019, a company spokesperson said, adding, Biocon Biologics has responded to the regulator on the eight observations from this inspection, in October last year.

from Moneycontrol Business News https://ift.tt/3bi6cNi
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...